1-173825320-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018122.5(DARS2):c.91A>G(p.Arg31Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,613,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018122.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DARS2 | NM_018122.5 | c.91A>G | p.Arg31Gly | missense_variant | Exon 1 of 17 | ENST00000649689.2 | NP_060592.2 | |
DARS2 | NM_001365212.1 | c.91A>G | p.Arg31Gly | missense_variant | Exon 1 of 16 | NP_001352141.1 | ||
DARS2 | NM_001365213.2 | c.91A>G | p.Arg31Gly | missense_variant | Exon 1 of 14 | NP_001352142.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000437 AC: 11AN: 251472Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135918
GnomAD4 exome AF: 0.000237 AC: 347AN: 1461628Hom.: 0 Cov.: 30 AF XY: 0.000228 AC XY: 166AN XY: 727130
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 31 of the DARS2 protein (p.Arg31Gly). This variant is present in population databases (rs140881109, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with DARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1397631). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
The c.91A>G (p.R31G) alteration is located in exon 1 (coding exon 1) of the DARS2 gene. This alteration results from a A to G substitution at nucleotide position 91, causing the arginine (R) at amino acid position 31 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at